NovoCure Limited (NVCR) stock is soaring today: Why is it so?
ST Staff
April 13, 2021
NovoCure Limited (NVCR) announced an update related to its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4 non-small cell lung